Tchiasso Dora, Mendjime Patricia, Fai Karl Njuwa, Wandji Brenda S Nana, Yuya Francis, Youm Éric, Stanton Amelia M, Karimu Ismaila, Bebell Lisa M, Matchim Lucrece, Buri Bongkiyung D, Ntone Rodrigue, Yonta Cyrille, Tchame Claudric R, Essaka Rachelle, Eyong Justin B, Ngosso Audrey, Nanda Herwin, Nsaibirni Robert, Ndifon Mark, Eteki Lucrèce, Mandeng Nadia, Bisseck Anne-Cécile Zoung-Kani, Koku Modeste T, Epée Emilienne, Mballa Georges-Alain Etoundi, Ndoula Shalom Tchocfe, Esso Linda, Boum Yap
Public Health Emergency Operation Center, Ministry of Public Health, Yaoundé, Cameroon.
Epicentre, Yaoundé, Cameroon.
J Public Health Afr. 2024 Oct 24;15(1):578. doi: 10.4102/jphia.v15i1.578. eCollection 2024.
Little is known about attitudes towards COVID-19 vaccination in sub-Saharan Africa, where immunisation coverage is the lowest in the world.
The study aimed to identify factors associated with COVID-19 vaccine hesitancy and uptake in Cameroon, and assess changes in these factors over a period of time.
The study was conducted in the ten regions of Cameroon.
The authors conducted a two-phase cross-sectional survey in the 10 regions of Cameroon, from July 2021 to August 2021 (Phase one) and from August 2022 to September 2022 (Phase two). We analysed reasons for vaccine hesitancy descriptively and used logistic regression to assess factors associated with hesitancy.
Overall, we enrolled 12 109 participants: 6567 (54.23%) in Phase one and 5542 (45.77%) in Phase two. Of these, 8009 (66.14%) were not interested in receiving the COVID-19 vaccine ( = 4176 in Phase one, = 3833 in Phase two). The refusal rate increased significantly in the northern region from 27.00% in Phase 1 to 60.00% in Phase two. The leading contributor to COVID-19 vaccine hesitancy was fear that the vaccine was dangerous, which was significantly associated (95% confidence interval [CI], < 0.05%) with vaccine refusal in both phases. Overall, 32.90% of participants ( = 2578) perceived the COVID-19 vaccine to be dangerous. Advanced age, male gender, Muslim religion and low level of education were associated with vaccine acceptance. Participants reported that healthcare workers were the most trusted source of information about the COVID-19 vaccine by 5005 (42.84%) participants.
Despite the investment of the Ministry of Health and its partners in community engagement, focussing on communication about the vaccine efficacy, tolerance and potential adverse events, fear of the vaccine remains high, likely leading to vaccine hesitancy in Cameroon between 2021 and 2022.
The study highlight regional variations in COVID-19 vaccine acceptance in Cameroon, with factors age, gender, religion and education influencing willingness to vaccine. Trust in health workers was high, indicating that, tailored, community-led vaccination strategies are key for improving vaccine uptake, not only for COVID-19 but also for future epidemics.
在撒哈拉以南非洲,免疫接种覆盖率是全球最低的,人们对新冠疫苗接种的态度鲜为人知。
本研究旨在确定喀麦隆与新冠疫苗犹豫和接种相关的因素,并评估这些因素在一段时间内的变化。
本研究在喀麦隆的十个地区开展。
作者于2021年7月至2021年8月(第一阶段)以及2022年8月至2022年9月(第二阶段)在喀麦隆的10个地区进行了两阶段横断面调查。我们对疫苗犹豫的原因进行了描述性分析,并使用逻辑回归评估与犹豫相关的因素。
总体而言,我们招募了12109名参与者:第一阶段6567名(54.23%),第二阶段5542名(45.77%)。其中,8009名(66.14%)对接种新冠疫苗不感兴趣(第一阶段4176名,第二阶段3833名)。北部地区的拒绝率从第一阶段的27.00%显著上升至第二阶段的60.00%。导致新冠疫苗犹豫的主要因素是担心疫苗危险,这在两个阶段均与拒绝接种疫苗显著相关(95%置信区间[CI],<0.05%)。总体而言,32.90%的参与者(2578名)认为新冠疫苗危险。高龄、男性、穆斯林宗教信仰和低教育水平与疫苗接受度相关。5005名(42.84%)参与者报告称,医护人员是关于新冠疫苗最值得信赖的信息来源。
尽管卫生部及其合作伙伴在社区参与方面投入了精力,重点是宣传疫苗的有效性、耐受性和潜在不良事件,但对疫苗的恐惧仍然很高,这可能导致喀麦隆在2021年至2022年期间出现疫苗犹豫。
该研究突出了喀麦隆在新冠疫苗接受度方面的地区差异,年龄、性别、宗教和教育等因素影响接种意愿。对医护人员的信任度很高,这表明量身定制的、社区主导的疫苗接种策略是提高疫苗接种率的关键,不仅适用于新冠疫苗,也适用于未来的疫情。